Reversible Bone Marrow Dysplasia in Patients with Systemic Lupus Erythematosus

Objective Several reports of bone marrow dysplasia in patients with systemic lupus erythematosus (SLE) have been published. However, the reports are restricted primarily to descriptions of the erythroid lineage; no follow-up studies have been reported, and the clinical significance of the dysplasias...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Internal Medicine 2008, Vol.47(8), pp.737-742
Hauptverfasser: Oka, Yumiko, Kameoka, Junichi, Hirabayashi, Yasuhiko, Takahashi, Reiko, Ishii, Tomonori, Sasaki, Takeshi, Harigae, Hideo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 742
container_issue 8
container_start_page 737
container_title Internal Medicine
container_volume 47
creator Oka, Yumiko
Kameoka, Junichi
Hirabayashi, Yasuhiko
Takahashi, Reiko
Ishii, Tomonori
Sasaki, Takeshi
Harigae, Hideo
description Objective Several reports of bone marrow dysplasia in patients with systemic lupus erythematosus (SLE) have been published. However, the reports are restricted primarily to descriptions of the erythroid lineage; no follow-up studies have been reported, and the clinical significance of the dysplasias is unknown. Therefore, in the present study, the dysplasias noted in bone marrow aspirates obtained from SLE patients were characterized. Patients and Methods The smears of bone marrow aspirates obtained from 17 SLE patients who had bone marrow aspiration due to cytopenia (WBC
doi_str_mv 10.2169/internalmedicine.47.0607
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69113304</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69113304</sourcerecordid><originalsourceid>FETCH-LOGICAL-c472t-3e0a03c4828155a07e7fd6ed8bb04bd803f5865cbffd18922ebc2dc290cc419e3</originalsourceid><addsrcrecordid>eNptkMtu2zAQRYmiQeOk_YWCq-zk8CWRXLZpXoDzQNquCYoa1Qz0cDlUAv99FdhIgCKbmcWcewc4hFDOloJX9jQOGdLgux6aGOIAS6WXrGL6A1lwqWyhhSw_kgWz3BRiHofkCPGRMWm0FZ_IITdKcG7Zgtw-wBMkjHUH9Ps4AL3xKY3P9McWN53H6Gkc6L3PEYaM9DnmNf25xQx9DHQ1bSak52mb19D7POKEn8lB6zuEL_t9TH5fnP86uypWd5fXZ99WRVBa5EIC80wGZYThZemZBt02FTSmrpmqG8NkW5qqDHXbNtxYIaAOognCshAUtyCPycmud5PGvxNgdn3EAF3nBxgndJXlXEqmZtDswJBGxASt26TY-7R1nLkXl-5_l05p9-Jyjn7d_5jq-fgW3MubgdUOeMTs_8Ar4FOOoYN3m81uaKlfsbD2ycEg_wG-qZOA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69113304</pqid></control><display><type>article</type><title>Reversible Bone Marrow Dysplasia in Patients with Systemic Lupus Erythematosus</title><source>J-STAGE Free</source><source>MEDLINE</source><creator>Oka, Yumiko ; Kameoka, Junichi ; Hirabayashi, Yasuhiko ; Takahashi, Reiko ; Ishii, Tomonori ; Sasaki, Takeshi ; Harigae, Hideo</creator><creatorcontrib>Oka, Yumiko ; Kameoka, Junichi ; Hirabayashi, Yasuhiko ; Takahashi, Reiko ; Ishii, Tomonori ; Sasaki, Takeshi ; Harigae, Hideo</creatorcontrib><description>Objective Several reports of bone marrow dysplasia in patients with systemic lupus erythematosus (SLE) have been published. However, the reports are restricted primarily to descriptions of the erythroid lineage; no follow-up studies have been reported, and the clinical significance of the dysplasias is unknown. Therefore, in the present study, the dysplasias noted in bone marrow aspirates obtained from SLE patients were characterized. Patients and Methods The smears of bone marrow aspirates obtained from 17 SLE patients who had bone marrow aspiration due to cytopenia (WBC&lt;1,500/μl, or Hb&lt;10.5 g/dl, or platelet count &lt;10×104/μl) were examined retrospectively. Of the 17 patients, 4 had a repeat bone marrow aspiration during follow-up. Clinical and laboratory data were obtained from the medical records. Results Of the 17 SLE patients, 12 had dysplasias, including: erythroid cell multinuclearity (trinuclear or more) (5 patients), megaloblastoid changes (4), pseudo-Pelger abnormalities (6), annular nuclear myeloid cells (2), separated nuclear megakaryocytes (4), and micromegakaryocytes (5). In the 4 patients who had follow-up bone marrow aspiration, these dysplasias were correlated with disease activity; some abnormalities disappeared with remission of SLE. Diffuse proliferative glomerulonephritis (3 patients) and cerebral lupus/neuropsychiatric lupus (4 patients) were seen only in patients with dysplasia. Conclusion This study found that bone marrow dysplasia can be observed in all lineage cells of SLE patients, and that the dysplasia is reversible during the course of the disease. The presence of dysplasias appears to be associated with disease severity.</description><identifier>ISSN: 0918-2918</identifier><identifier>EISSN: 1349-7235</identifier><identifier>DOI: 10.2169/internalmedicine.47.0607</identifier><identifier>PMID: 18421190</identifier><language>eng</language><publisher>Japan: The Japanese Society of Internal Medicine</publisher><subject>Adolescent ; Adult ; Biopsy, Fine-Needle ; Bone Diseases, Developmental - etiology ; Bone Diseases, Developmental - pathology ; bone marrow ; Bone Marrow - pathology ; Child ; cytopenia ; dysplasia ; Female ; Humans ; Lupus Erythematosus, Systemic - complications ; Lupus Erythematosus, Systemic - pathology ; Male ; Megakaryocytes - pathology ; Megaloblasts - pathology ; Middle Aged ; myelodysplastic syndrome ; Myeloid Cells - pathology ; Remission, Spontaneous ; Retrospective Studies ; Severity of Illness Index ; systemic lupus erythematosus</subject><ispartof>Internal Medicine, 2008, Vol.47(8), pp.737-742</ispartof><rights>2008 by The Japanese Society of Internal Medicine</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c472t-3e0a03c4828155a07e7fd6ed8bb04bd803f5865cbffd18922ebc2dc290cc419e3</citedby><cites>FETCH-LOGICAL-c472t-3e0a03c4828155a07e7fd6ed8bb04bd803f5865cbffd18922ebc2dc290cc419e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1883,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18421190$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Oka, Yumiko</creatorcontrib><creatorcontrib>Kameoka, Junichi</creatorcontrib><creatorcontrib>Hirabayashi, Yasuhiko</creatorcontrib><creatorcontrib>Takahashi, Reiko</creatorcontrib><creatorcontrib>Ishii, Tomonori</creatorcontrib><creatorcontrib>Sasaki, Takeshi</creatorcontrib><creatorcontrib>Harigae, Hideo</creatorcontrib><title>Reversible Bone Marrow Dysplasia in Patients with Systemic Lupus Erythematosus</title><title>Internal Medicine</title><addtitle>Intern. Med.</addtitle><description>Objective Several reports of bone marrow dysplasia in patients with systemic lupus erythematosus (SLE) have been published. However, the reports are restricted primarily to descriptions of the erythroid lineage; no follow-up studies have been reported, and the clinical significance of the dysplasias is unknown. Therefore, in the present study, the dysplasias noted in bone marrow aspirates obtained from SLE patients were characterized. Patients and Methods The smears of bone marrow aspirates obtained from 17 SLE patients who had bone marrow aspiration due to cytopenia (WBC&lt;1,500/μl, or Hb&lt;10.5 g/dl, or platelet count &lt;10×104/μl) were examined retrospectively. Of the 17 patients, 4 had a repeat bone marrow aspiration during follow-up. Clinical and laboratory data were obtained from the medical records. Results Of the 17 SLE patients, 12 had dysplasias, including: erythroid cell multinuclearity (trinuclear or more) (5 patients), megaloblastoid changes (4), pseudo-Pelger abnormalities (6), annular nuclear myeloid cells (2), separated nuclear megakaryocytes (4), and micromegakaryocytes (5). In the 4 patients who had follow-up bone marrow aspiration, these dysplasias were correlated with disease activity; some abnormalities disappeared with remission of SLE. Diffuse proliferative glomerulonephritis (3 patients) and cerebral lupus/neuropsychiatric lupus (4 patients) were seen only in patients with dysplasia. Conclusion This study found that bone marrow dysplasia can be observed in all lineage cells of SLE patients, and that the dysplasia is reversible during the course of the disease. The presence of dysplasias appears to be associated with disease severity.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Biopsy, Fine-Needle</subject><subject>Bone Diseases, Developmental - etiology</subject><subject>Bone Diseases, Developmental - pathology</subject><subject>bone marrow</subject><subject>Bone Marrow - pathology</subject><subject>Child</subject><subject>cytopenia</subject><subject>dysplasia</subject><subject>Female</subject><subject>Humans</subject><subject>Lupus Erythematosus, Systemic - complications</subject><subject>Lupus Erythematosus, Systemic - pathology</subject><subject>Male</subject><subject>Megakaryocytes - pathology</subject><subject>Megaloblasts - pathology</subject><subject>Middle Aged</subject><subject>myelodysplastic syndrome</subject><subject>Myeloid Cells - pathology</subject><subject>Remission, Spontaneous</subject><subject>Retrospective Studies</subject><subject>Severity of Illness Index</subject><subject>systemic lupus erythematosus</subject><issn>0918-2918</issn><issn>1349-7235</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkMtu2zAQRYmiQeOk_YWCq-zk8CWRXLZpXoDzQNquCYoa1Qz0cDlUAv99FdhIgCKbmcWcewc4hFDOloJX9jQOGdLgux6aGOIAS6WXrGL6A1lwqWyhhSw_kgWz3BRiHofkCPGRMWm0FZ_IITdKcG7Zgtw-wBMkjHUH9Ps4AL3xKY3P9McWN53H6Gkc6L3PEYaM9DnmNf25xQx9DHQ1bSak52mb19D7POKEn8lB6zuEL_t9TH5fnP86uypWd5fXZ99WRVBa5EIC80wGZYThZemZBt02FTSmrpmqG8NkW5qqDHXbNtxYIaAOognCshAUtyCPycmud5PGvxNgdn3EAF3nBxgndJXlXEqmZtDswJBGxASt26TY-7R1nLkXl-5_l05p9-Jyjn7d_5jq-fgW3MubgdUOeMTs_8Ar4FOOoYN3m81uaKlfsbD2ycEg_wG-qZOA</recordid><startdate>20080101</startdate><enddate>20080101</enddate><creator>Oka, Yumiko</creator><creator>Kameoka, Junichi</creator><creator>Hirabayashi, Yasuhiko</creator><creator>Takahashi, Reiko</creator><creator>Ishii, Tomonori</creator><creator>Sasaki, Takeshi</creator><creator>Harigae, Hideo</creator><general>The Japanese Society of Internal Medicine</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20080101</creationdate><title>Reversible Bone Marrow Dysplasia in Patients with Systemic Lupus Erythematosus</title><author>Oka, Yumiko ; Kameoka, Junichi ; Hirabayashi, Yasuhiko ; Takahashi, Reiko ; Ishii, Tomonori ; Sasaki, Takeshi ; Harigae, Hideo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c472t-3e0a03c4828155a07e7fd6ed8bb04bd803f5865cbffd18922ebc2dc290cc419e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Biopsy, Fine-Needle</topic><topic>Bone Diseases, Developmental - etiology</topic><topic>Bone Diseases, Developmental - pathology</topic><topic>bone marrow</topic><topic>Bone Marrow - pathology</topic><topic>Child</topic><topic>cytopenia</topic><topic>dysplasia</topic><topic>Female</topic><topic>Humans</topic><topic>Lupus Erythematosus, Systemic - complications</topic><topic>Lupus Erythematosus, Systemic - pathology</topic><topic>Male</topic><topic>Megakaryocytes - pathology</topic><topic>Megaloblasts - pathology</topic><topic>Middle Aged</topic><topic>myelodysplastic syndrome</topic><topic>Myeloid Cells - pathology</topic><topic>Remission, Spontaneous</topic><topic>Retrospective Studies</topic><topic>Severity of Illness Index</topic><topic>systemic lupus erythematosus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Oka, Yumiko</creatorcontrib><creatorcontrib>Kameoka, Junichi</creatorcontrib><creatorcontrib>Hirabayashi, Yasuhiko</creatorcontrib><creatorcontrib>Takahashi, Reiko</creatorcontrib><creatorcontrib>Ishii, Tomonori</creatorcontrib><creatorcontrib>Sasaki, Takeshi</creatorcontrib><creatorcontrib>Harigae, Hideo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Internal Medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Oka, Yumiko</au><au>Kameoka, Junichi</au><au>Hirabayashi, Yasuhiko</au><au>Takahashi, Reiko</au><au>Ishii, Tomonori</au><au>Sasaki, Takeshi</au><au>Harigae, Hideo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reversible Bone Marrow Dysplasia in Patients with Systemic Lupus Erythematosus</atitle><jtitle>Internal Medicine</jtitle><addtitle>Intern. Med.</addtitle><date>2008-01-01</date><risdate>2008</risdate><volume>47</volume><issue>8</issue><spage>737</spage><epage>742</epage><pages>737-742</pages><issn>0918-2918</issn><eissn>1349-7235</eissn><abstract>Objective Several reports of bone marrow dysplasia in patients with systemic lupus erythematosus (SLE) have been published. However, the reports are restricted primarily to descriptions of the erythroid lineage; no follow-up studies have been reported, and the clinical significance of the dysplasias is unknown. Therefore, in the present study, the dysplasias noted in bone marrow aspirates obtained from SLE patients were characterized. Patients and Methods The smears of bone marrow aspirates obtained from 17 SLE patients who had bone marrow aspiration due to cytopenia (WBC&lt;1,500/μl, or Hb&lt;10.5 g/dl, or platelet count &lt;10×104/μl) were examined retrospectively. Of the 17 patients, 4 had a repeat bone marrow aspiration during follow-up. Clinical and laboratory data were obtained from the medical records. Results Of the 17 SLE patients, 12 had dysplasias, including: erythroid cell multinuclearity (trinuclear or more) (5 patients), megaloblastoid changes (4), pseudo-Pelger abnormalities (6), annular nuclear myeloid cells (2), separated nuclear megakaryocytes (4), and micromegakaryocytes (5). In the 4 patients who had follow-up bone marrow aspiration, these dysplasias were correlated with disease activity; some abnormalities disappeared with remission of SLE. Diffuse proliferative glomerulonephritis (3 patients) and cerebral lupus/neuropsychiatric lupus (4 patients) were seen only in patients with dysplasia. Conclusion This study found that bone marrow dysplasia can be observed in all lineage cells of SLE patients, and that the dysplasia is reversible during the course of the disease. The presence of dysplasias appears to be associated with disease severity.</abstract><cop>Japan</cop><pub>The Japanese Society of Internal Medicine</pub><pmid>18421190</pmid><doi>10.2169/internalmedicine.47.0607</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0918-2918
ispartof Internal Medicine, 2008, Vol.47(8), pp.737-742
issn 0918-2918
1349-7235
language eng
recordid cdi_proquest_miscellaneous_69113304
source J-STAGE Free; MEDLINE
subjects Adolescent
Adult
Biopsy, Fine-Needle
Bone Diseases, Developmental - etiology
Bone Diseases, Developmental - pathology
bone marrow
Bone Marrow - pathology
Child
cytopenia
dysplasia
Female
Humans
Lupus Erythematosus, Systemic - complications
Lupus Erythematosus, Systemic - pathology
Male
Megakaryocytes - pathology
Megaloblasts - pathology
Middle Aged
myelodysplastic syndrome
Myeloid Cells - pathology
Remission, Spontaneous
Retrospective Studies
Severity of Illness Index
systemic lupus erythematosus
title Reversible Bone Marrow Dysplasia in Patients with Systemic Lupus Erythematosus
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T12%3A40%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reversible%20Bone%20Marrow%20Dysplasia%20in%20Patients%20with%20Systemic%20Lupus%20Erythematosus&rft.jtitle=Internal%20Medicine&rft.au=Oka,%20Yumiko&rft.date=2008-01-01&rft.volume=47&rft.issue=8&rft.spage=737&rft.epage=742&rft.pages=737-742&rft.issn=0918-2918&rft.eissn=1349-7235&rft_id=info:doi/10.2169/internalmedicine.47.0607&rft_dat=%3Cproquest_cross%3E69113304%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69113304&rft_id=info:pmid/18421190&rfr_iscdi=true